https://www.targetedonc.com/view/promising-efficacy-and-safety-signals-shown-with-encorafenib-triplet-in-braf-v600e-mcrc
0
0
1/26/23 at 7:13pm
Organization
Targetedonc.com
Author
Nichole Tucker
35 words
0
Comments
Findings from the phase 3 SUNLIGHT study showed that adding bevacizumab to trifluridine/tipiracil boosted overall survival in metastatic colorectal cancer.
You are the first to view
Create an account
or login to join the discussion